Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Multiple Ascending-dose Study of EQ001 in Subjects With Systemic Lupus Erythematosus With or Without Active Proliferative Lupus Nephritis

NCT04128579 is registered in ClinicalTrials.gov with Biocon Limited as lead sponsor.

NCT NCT04128579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04128579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Multiple Ascending-dose Study of EQ001 in Subjects With Systemic Lupus Erythematosus With or Without Active Proliferative Lupus Nephritis
Lead sponsor
Biocon Limited
Phase
Phase 1
Overall status
Completed
Start date
October 1, 2019
Completion date
January 18, 2024
Enrollment
52 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

lupus erythematosus, lupus nephritis